We are monitoring the impact of COVID-19 & Recession alarm on Europe RIA Market Get in touch with us for detailed analysis Know More
Share on

Europe Radioimmunoassay Market Research Report – Segmented By Type, End User, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3557
Pages: 145

Europe RIA Market Size (2022 to 2027)

The size of the Europe Radioimmunoassay Market was valued at USD 97.64 million in 2022. It is further projected to be growing at a CAGR of 3.33% and worth USD 115.01 million by 2027.

The increasing prevalence of chronic and infectious diseases is primarily driving the radioimmunoassay market in the European region. The assay's accuracy and sensitivity are determined mainly by the quality of antigens and antibodies used, as well as the separation procedures used. In addition, the in-vitro process of the assay is carried out using radioimmunoassay kits.

Governments and private organizations across the region are taking initiatives and investing in the healthcare sector to develop infrastructure, research, and development activities. Central laboratory tests and point of care tests are encouraging market growth. In addition, according to Commonwealth Fund statistics released in January 2019, heart disease is one of the significant causes of mortality in Germany, accounting for about 38 percent of all deaths. 

On the other hand, increasing government initiatives help develop tools such as immunoassay analyzers, which are expected to provide lucrative growth opportunities to the market growth. Furthermore, technological advancements in the healthcare sector, increasing adoption of automated immunoassay analyzers, and growing healthcare spending are surging the market growth. In addition, the emergence of the covid-19 pandemic has led the radioimmunoassay market. As a result, the consumption of immunoassays has been significantly increased during the pandemic period. This has created lucrative opportunities for companies to produce innovative and advanced analyzers. 

However, factors such as the short shelf life of radiolabelled substances, the presence of hazardous, radioactive elements in the assay, and the disposal of radioactive waste are hampering the growth rate of the European radioimmunoassay market.

This research report on the European radioimmunoassay market has been segmented and sub-segmented into the following categories:

By Type: 

  • Reagents and Kits
  • Analyzers

By End User: 

  • Hospitals
  • Pharmaceutical Industry and CRO
  • Clinical Diagnostic Laboratories

By Application: 

  • Research
  • Clinical Diagnostics

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Based on the region, the European region has the second-highest market share globally, only behind the likes of North America, albeit with a low CAGR rate. The low growth rate of the region can be attributed to the fact that most countries in the region are at their pinnacle of development, and the room to grow is fast decreasing.

The European market accounted for a substantial share in the global radioimmunoassay market in 2020, and it is anticipated to continue its dominance throughout the forecast period. The regional market growth is attributed to the presence of well-established healthcare infrastructure, the presence of key market companies, and favorable reimbursement policies. In addition, the European radioimmunoassay market growth is expanded by emerging countries such as Germany, the UK, France, Italy, and Spain. 

Germany accounted for the largest share of the radioimmunoassay market, likely to witness a significant share during the forecast period. The market growth is driven by the increasing incidence of cancer, Growing awareness, and Urbanization with a heavy population. Also, the Presence of CROs and pharmaceutical industries, technological advancements in the healthcare sector, and the increasing focus of key market players on developing new products are accelerating the market growth. Germany accounts for the high percentage of diabetes in Europe. According to the International Diabetes Federation, around 15.3 percent of adults in Germany,

Similarly, the UK is expected to register a promising share in the radioimmunoassay market in the coming years due to the growing geriatric population and the rising need for quality and error-free results to ensure patient satisfaction and high healthcare spending. 

Furthermore, the other emerging countries such as Italy, Spain, and France are expected to witness a considerable share during the forecast period. In addition, a significant increase in research and development activities by the pharmaceutical and biopharmaceutical industries, the rising number of blood donations in blood banks, and continuous technological advancements contribute to the radioimmunoassay market.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the Europe radioimmunoassay market profiled in the report are DIAsource Immunoassays SA, Beckman Coulter, IBL International, PerkinElmer, DRG International, MP Biomedicals LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A, EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG, Stratec Biomedical AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Reagents and Kits                

                                5.1.3 Analyzers 

                                5.1.4  Y-o-Y Growth Analysis, By Type    

                                5.1.5  Market Attractiveness Analysis, By Type  

                                5.1.6  Market Share Analysis, By Type    

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Pharmaceutical Industry and CRO 

                                5.2.4 Clinical Diagnostic Laboratories       

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research  

                                5.3.3 Clinical Diagnostics               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Application

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DIAsource ImmunoAssays SA                             

                                8.1.1 Overview 

                                8.1.2 Type Analysis         

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter                     

                8.3 IBL International                       

                8.4 PerkinElmer                               

                8.5 DRG international                    

                8.6 MP Biomedicals                        

                8.7 Cisbio                            

                8.8 Euro Diagnostica AB                

                8.9 DiaSorin                       

                8.10 Stratec Biomedical                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  2. Europe Reagents and Kits Market, By Region, From 2022 - 2027 (USD Million)
  3. Europe Analyzers Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  5. Europe Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe Pharmaceutical Industry and CRO Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Academics Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Clinical Diagnostic Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  10. Europe Research Market, By Region, From 2022 - 2027 (USD Million)
  11. Europe Clinical Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  12. U.K. Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  13. U.K. Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  14. U.K. Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  15. Germany Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  16. Germany Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  17. Germany Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  18. France Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  19. France Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  20. France Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  21. Italy Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  22. Italy Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  23. Italy Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  24. Spain Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  25. Spain Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  26. Spain Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample